000 01441 a2200361 4500
005 20250513185934.0
264 0 _c19990902
008 199909s 0 0 eng d
022 _a0923-7534
024 7 _a10.1023/a:1026438801080
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aErba, E
245 0 0 _aThe metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cMay 1999
300 _a589-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBromodeoxyuridine
_xmetabolism
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMetalloendopeptidases
_xantagonists & inhibitors
650 0 4 _aOvarian Neoplasms
_xpathology
650 0 4 _aPhenylalanine
_xanalogs & derivatives
650 0 4 _aProtease Inhibitors
_xpharmacology
650 0 4 _aThiophenes
_xpharmacology
700 1 _aRonzoni, S
700 1 _aBassano, L
700 1 _aGiavazzi, R
700 1 _aD'Incalci, M
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 10
_gno. 5
_gp. 589-91
856 4 0 _uhttps://doi.org/10.1023/a:1026438801080
_zAvailable from publisher's website
999 _c10374030
_d10374030